No Detail Found!

Comparison of pre and post vaccinated covid-19 antibody titers in general population

Author(s)
Ali Haider Department of Allied Health Sciences, The University of Lahore,Gujrat Campus,Pakistan
Juwayria Omar Fazaia Medical College Islamabad,Pakistan
Hameed Mumtaz Durrani Shifa College of Medicine,Islamabad, Pakistan
Muhammad Afzal Shaheed Zulfiqar Ali Bhutto Medical University,G-8/3, Islamabad,Pakistan
Abid Ali Department of Allied Health Sciences, The University of Chenab,Gujrat, Pakistan
Akash John Department of Allied Health Sciences, The University of Chenab,Gujrat, Pakistan
Abstract
Objective: The aims and objectives of this study to examine the general population one year later following immunization for changes in anti-SARS-CoV-2 IgG levels. Methodology: The study enrolled 18,610 individuals, including rural and urban areas. The quantities of IgG antibodies were determined using an ELISA. Results: At 5-8 months following complete immunization, both vaccines produced comparable amounts of anti-SARS-CoV-2 IgG. On the other hand, BBIBP-CorV had a much lower IgG concentration. Anti-SARS-CoV-2 IgG levels in a large cohort of volunteers increased nine months after vaccination, indicating asymptomatic infection. Anti-SARS-CoV-2 IgG antibody levels were significantly higher following the booster dose than following the second dose. Antibodies began to build approximately five days after the booster dosage injection and peaked around the fourteenth day. Conclusion: Cut-off dates for the effectiveness of mRNA and vector vaccines appear to be 8-9 months and 5-6 months following vaccination, respectively. With the potential to have a significant impact on the virus's ongoing transmission, providing a booster dose was a brilliant idea.
Publication Details
Page(s) 36-42
DOI DOI not available
Published Journal: BMC journal of Medical Sciences, Volume: 4, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
SARS-CoV-2, mRNA., IgG antibody
0

Citations

0

Downloads

41

Views